BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 487808)

  • 41. Clinical evaluation of U-coil progesterone releasing device versus inert U-coil IUD.
    Serour GI; Hamza A; El Sheikha Z; Hefnawi FI
    Popul Sci; 1982; (3):121-35. PubMed ID: 12266213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study.
    Wilson JC
    Am J Obstet Gynecol; 1989 Feb; 160(2):391-6. PubMed ID: 2916624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China.
    Xu JX; Rivera R; Dunson TR; Zhuang LQ; Yang XL; Ma GT; Chi IC
    Contraception; 1996 Jul; 54(1):33-8. PubMed ID: 8804806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
    Malhotra N; Chaudhury RR
    Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical experience with today's IUDs.
    Pasquale S
    Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S25-9. PubMed ID: 8972499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR).
    Sivin I; Stern J
    Fertil Steril; 1994 Jan; 61(1):70-7. PubMed ID: 8293847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized clinical study of the TCu-380 A and the TCu-200 B. IUDs.
    Kandil OF; El-sheikha Z; Hamza A
    Popul Sci; 1991 Jan; 10():35-40. PubMed ID: 12284660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative study of the clinical performance of two copper-releasing IUDs, Nova-T & Copper-T-200 in Lagos, Nigeria.
    Oyediran MA; Akinla O
    Contraception; 1980 Aug; 22(2):115-22. PubMed ID: 7004771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative studies on menstrual blood loss in IUD users.
    Andrade AT; Pizarro Orchard E
    Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the Progestasert on the menstrual pattern, ovarian steroids and endometrium.
    Wan LS; Hsu YC; Ganguly M; Bigelow B
    Contraception; 1977 Oct; 16(4):417-34. PubMed ID: 923252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical trial of the Delta-T intrauterine device: immediate postpartum insertion.
    Brenner PF
    Contraception; 1983 Aug; 28(2):135-47. PubMed ID: 6357630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of modified intrauterine device (IUD) TCu 380 with chromium filaments in the immediate postpartum].
    Hernández Valencia M; Becerril Flores LC
    Ginecol Obstet Mex; 2000 Feb; 68():70-6. PubMed ID: 10774108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Contraception; 1980 Feb; 21(2):155-64. PubMed ID: 6768490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Values of steroidal intrauterine contraception for developing countries.
    Pharriss B; Mitchell C
    J Steroid Biochem; 1979 Jul; 11(1B):469-73. PubMed ID: 491618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The Progestasert system].
    Mall-Haefeli M
    Gynakol Rundsch; 1978; 18(3-4):253-62. PubMed ID: 569628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Copper-7 intrauterine device (Gravigard). Report of experience].
    Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
    Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interval iud insertion in parous women: a randomized multicentre comparative trial of the Lippes Loop D, TCu220c and the Copper 7.
    Contraception; 1982 Jul; 26(1):1-22. PubMed ID: 7128130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.